在 T 细胞和巨噬细胞之间建立联盟，增强癌症免疫疗法。

IF 3.2 4区医学 Q3 CELL BIOLOGY

Immunology & Cell Biology Pub Date : 2024-06-27 DOI:10.1111/imcb.12799

Tessa Gargett, Lisa M Ebert

引用次数: 0

摘要

Yamada-Hunter 等人的一项新研究揭示了一种促进巨噬细胞与工程 T 细胞之间协同作用而非拮抗作用的新方法，从而增强了抗肿瘤免疫力。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

Striking an alliance between T cells and macrophages for enhanced cancer immunotherapy

查看原文本刊更多论文

Striking an alliance between T cells and macrophages for enhanced cancer immunotherapy

A new study by Yamada-Hunter et al. reveals a novel approach to promote synergy—rather than antagonism—between macrophages and engineered T cells, leading to enhanced antitumor immunity.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Immunology & Cell Biology 医学-免疫学

CiteScore

7.50

自引率

2.50%

发文量

审稿时长

4-8 weeks

期刊介绍： The Australasian Society for Immunology Incorporated (ASI) was created by the amalgamation in 1991 of the Australian Society for Immunology, formed in 1970, and the New Zealand Society for Immunology, formed in 1975. The aim of the Society is to encourage and support the discipline of immunology in the Australasian region. It is a broadly based Society, embracing clinical and experimental, cellular and molecular immunology in humans and animals. The Society provides a network for the exchange of information and for collaboration within Australia, New Zealand and overseas. ASI members have been prominent in advancing biological and medical research worldwide. We seek to encourage the study of immunology in Australia and New Zealand and are active in introducing young scientists to the discipline.